Infographic- Why Fucoxanthin is the optimal supplement for liver health?
Metabolic Syndrome, the major health hazard of the modern world, is a pathological condition, which results from a clustering of at least 2-3 of the following conditions simultaneously: abdominal obesity, insulin resistance, hypertension and hyperlipidemia. It is caused by the consumption of high calorie, low fiber foods and decreased physical activity, which can potentially lead to cardiovascular diseases or type 2 diabetes.
Metabolic syndrome is a key risk factor in developing Non-Alcoholic Fatty Liver (NAFL) condition, a dangerous build-up of lipid deposits in the liver. NAFL is the most common liver abnormality, affecting 1 out of 4 people. Untreated NAFL may progress to severe liver damage.
Learn more about Solabia-Algatech Nutritions’ Fucoxanthin FucoVital™ and its impact on the liver:
Fucovital™ by Solabia-Algatech Nutrition is an innovative composition comprising of 3% fucoxanthin, derived from the Phaeodactylum Tricornutum microalgae.
Fucovital™ is the only fucoxanthin extract that has obtained a New Dietary Ingredient Notification (NDIN) by the US-FDA.
Fucovital™ is manufactured in an eco-friendly closed system cultivation technology, fully controlled and exposed to the natural sunlight of the Israeli Arava desert.
Using microalgae is the most ecologically friendly and sustainable method to produce fucoxanthin, and it contains concentrations of fucoxanthin that are several hundred times higher when compared to seaweed.